(19)
(11) EP 1 229 795 A2

(12)

(88) Date of publication A3:
08.11.2001

(43) Date of publication:
14.08.2002 Bulletin 2002/33

(21) Application number: 00978340.8

(22) Date of filing: 02.11.2000
(51) International Patent Classification (IPC)7: A01N 63/00, C12P 21/06, C12N 15/00, C12N 5/00, C07K 14/00, C07K 16/00
(86) International application number:
PCT/US0030/237
(87) International publication number:
WO 0132/128 (10.05.2001 Gazette 2001/19)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 03.11.1999 US 432768

(71) Applicants:
  • HUMAN GENOME SCIENCES, INC.
    Rockville, MD 20850-3338 (US)
  • BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Boston, MA 02115 (US)
  • SMITHKLINE BEECHAM CORPORATION
    King of Prussia, PA 19406-0939 (US)

(72) Inventors:
  • ULLRICH, Stephen
    Rockville, MD 20853 (US)
  • SEIBEL, George
    Saint Davis, PA 19087 (US)
  • LI, Haodong
    Gaithersburg, MD 20878 (US)
  • LUSCINSKAS, Francis, W.
    Milton, MA 02186 (US)

(74) Representative: VOSSIUS & PARTNER 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) HUMAN CHEMOKINE BETA-13